{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T21:11:58Z","timestamp":1764364318279},"reference-count":45,"publisher":"Japanese Society for Spine Surgery and Related Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Spine Surg Relat Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.22603\/ssrr.1.2017-0023","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T22:16:57Z","timestamp":1511734617000},"page":"211-217","source":"Crossref","is-referenced-by-count":17,"title":["MicroRNA transcriptome analysis on hypertrophy of ligamentum flavum in patients with lumbar spinal stenosis"],"prefix":"10.22603","volume":"1","author":[{"given":"Taiki","family":"Mori","sequence":"first","affiliation":[{"name":"Medical Genome Center, National Center for Geriatrics and Gerontology (NCGG)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, NCGG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunori","family":"Kayano","sequence":"additional","affiliation":[{"name":"Medical Genome Center, National Center for Geriatrics and Gerontology (NCGG)"},{"name":"Research Center for Global Agromedicine, Obihiro University of Agriculture and Veterinary Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development (NRICHD)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Oboki","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development (NRICHD)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development (NRICHD)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, NCGG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumpei","family":"Niida","sequence":"additional","affiliation":[{"name":"Medical Genome Center, National Center for Geriatrics and Gerontology (NCGG)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Bone and Joint Disease, NCGG"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"9891","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Katz JN, Harris MB. Clinical practice. Lumbar spinal stenosis. The New England JOurnal of Medicine. 2008;358 (8):818-25.","DOI":"10.1056\/NEJMcp0708097"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Siebert E, Pruss H, Klingebiel R, et al. Lumbar spinal stenosis: syndrome, diagnostics and treatment. Nature Reviews Neurology. 2009;5 (7):392-403.","DOI":"10.1038\/nrneurol.2009.90"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sairyo K, Biyani A, Goel V, et al. Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments. Spine. 2005;30 (23):2649-56.","DOI":"10.1097\/01.brs.0000188117.77657.ee"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schrader PK, Grob D, Rahn BA, et al. Histology of the ligamentum flavum in patients with degenerative lumbar spinal stenosis. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 1999;8 (4):323-8.","DOI":"10.1007\/s005860050181"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakamura T, Okada T, Endo M, et al. Angiopoietin-like protein 2 induced by mechanical stress accelerates degeneration and hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis. PloS One. 2014;9 (1):e85542.","DOI":"10.1371\/journal.pone.0085542"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakamura T, Okada T, Endo M, et al. Angiopoietin-like protein 2 promotes inflammatory conditions in the ligamentum flavum in the pathogenesis of lumbar spinal canal stenosis by activating interleukin-6 expression. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2015;24 (9):2001-9.","DOI":"10.1007\/s00586-015-3835-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Xu YQ, Zhang ZH, Zheng YF, et al. MicroRNA-221 regulates hypertrophy of ligamentum flavum in lumbar spinal stenosis by targeting TIMP-2. Spine. 2015.","DOI":"10.1097\/BRS.0000000000001226"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Honsawek S, Poonpukdee J, Chalermpanpipat C, et al. Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with increased bFGF expression. International Orthopaedics. 2013;37 (7):1387-92.","DOI":"10.1007\/s00264-013-1864-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhong ZM, Zha DS, Xiao WD, et al. Hypertrophy of ligamentum flavum in lumbar spine stenosis associated with the increased expression of connective tissue growth factor. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2011;29 (10):1592-7.","DOI":"10.1002\/jor.21431"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136 (2):215-33.","DOI":"10.1016\/j.cell.2009.01.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149 (3):515-24.","DOI":"10.1016\/j.cell.2012.04.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148 (6):1172-87.","DOI":"10.1016\/j.cell.2012.02.005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sakai Y, Ito S, Hida T, et al. Clinical outcome of lumbar spinal stenosis based on new classification according to hypertrophied ligamentum flavum. Journal of orthopaedic science: official journal of the Japanese Orthopaedic Association. 2017;22 (1):27-33.","DOI":"10.1016\/j.jos.2016.08.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kamita M, Mori T, Sakai Y, et al. Proteomic analysis of ligamentum flavum from patients with lumbar spinal stenosis. Proteomics. 2015;15 (9):1622-30.","DOI":"10.1002\/pmic.201400442"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yabe Y, Hagiwara Y, Ando A, et al. Chondrogenic and fibrotic process in the ligamentum flavum of patients with lumbar spinal canal stenosis. Spine. 2015;40 (7):429-35.","DOI":"10.1097\/BRS.0000000000000795"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Abbas J, Hamoud K, Masharawi YM, et al. Ligamentum flavum thickness in normal and stenotic lumbar spines. Spine. 2010;35 (12):1225-30.","DOI":"10.1097\/BRS.0b013e3181bfca15"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kolte VS, Khambatta S, Ambiye MV. Thickness of the ligamentum flavum: correlation with age and its asymmetry-an magnetic resonance imaging study. Asian Spine Journal. 2015;9 (2):245-53.","DOI":"10.4184\/asj.2015.9.2.245"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Munns JJ, Lee JY, Espinoza Orias AA, et al. Ligamentum flavum hypertrophy in asymptomatic and chronic low back pain subjects. PloS One. 2015;10 (5):e0128321.","DOI":"10.1371\/journal.pone.0128321"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Safak AA, Is M, Sevinc O, et al. The thickness of the ligamentum flavum in relation to age and gender. Clinical Anatomy. 2010;23 (1):79-83.","DOI":"10.1002\/ca.20883"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chen J, Liu Z, Zhong G, et al. Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level. Disease markers. 2014;2014:786543.","DOI":"10.1155\/2014\/786543"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chen X, Shi C, Wang C, et al. The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis. Scientific Reports. 2017;7:40958.","DOI":"10.1038\/srep40958"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hur JW, Bae T, Ye S, et al. Myofibroblast in the ligamentum flavum hypertrophic activity. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2017.","DOI":"10.1007\/s00586-017-4981-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. He XM, Zheng YQ, Liu SZ, et al. Altered Plasma MicroRNAs as Novel Biomarkers for Arteriosclerosis Obliterans. Journal of Atherosclerosis and Thrombosis. 2016;23 (2):196-206.","DOI":"10.5551\/jat.30775"},{"key":"24","unstructured":"24. Schrenk D. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochemical Pharmacology. 1998;55 (8):1155-62."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mimura J, Ema M, Sogawa K, et al. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes & Development. 1999;13 (1):20-5.","DOI":"10.1101\/gad.13.1.20"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wu D, Nishimura N, Kuo V, et al. Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-\/- mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011;31 (6):1260-7.","DOI":"10.1161\/ATVBAHA.110.220202"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. McMillan BJ, Bradfield CA. The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America. 2007;104 (4):1412-7.","DOI":"10.1073\/pnas.0607296104"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hahn ME, Allan LL, Sherr DH. Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochemical Pharmacology. 2009;77 (4):485-97.","DOI":"10.1016\/j.bcp.2008.09.016"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Stockinger B, Di Meglio P, Gialitakis M, et al. The aryl hydrocarbon receptor: multitasking in the immune system. Annual Review of Immunology. 2014;32:403-32.","DOI":"10.1146\/annurev-immunol-032713-120245"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chang X, Fan Y, Karyala S, et al. Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Molecular and Cellular Biology. 2007;27 (17):6127-39.","DOI":"10.1128\/MCB.00323-07"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Fernandez-Salguero P, Pineau T, Hilbert DM, et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science. 1995;268 (5211):722-6.","DOI":"10.1126\/science.7732381"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nature Medicine. 2013;19 (2):179-92.","DOI":"10.1038\/nm.3074"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149 (6):1192-205.","DOI":"10.1016\/j.cell.2012.05.012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Cai HX, Yayama T, Uchida K, et al. Cyclic tensile strain facilitates the ossification of ligamentum flavum through beta-catenin signaling pathway: in vitro analysis. Spine. 2012;37 (11):E639-46.","DOI":"10.1097\/BRS.0b013e318242a132"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Facchini FS, Hua N, Abbasi F, et al. Insulin resistance as a predictor of age-related diseases. The Journal of Clinical Endocrinology and Metabolism. 2001;86 (8):3574-8.","DOI":"10.1210\/jcem.86.8.7763"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. de la Fuente H, Cibrian D, Sanchez-Madrid F. Immunoregulatory molecules are master regulators of inflammation during the immune response. FEBS Letters. 2012;586 (18):2897-905.","DOI":"10.1016\/j.febslet.2012.07.032"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Perl A, Hanczko R, Telarico T, et al. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends in Molecular Medicine. 2011;17 (7):395-403.","DOI":"10.1016\/j.molmed.2011.01.014"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Silginer M, Burghardt I, Gramatzki D, et al. The aryl hydrocarbon receptor links integrin signaling to the TGF-beta pathway. Oncogene. 2016;35 (25):3260-71.","DOI":"10.1038\/onc.2015.387"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Zaher H, Fernandez-Salguero PM, Letterio J, et al. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Molecular Pharmacology. 1998;54 (2):313-21.","DOI":"10.1124\/mol.54.2.313"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Letamendia A, Labbe E, Attisano L. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. The Journal of Bone and Joint Surgery American Volume. 2001;83-A Suppl 1 (Pt 1):S31-9.","DOI":"10.2106\/00004623-200100001-00005"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Tschumperlin DJ, Liu F, Tager AM. Biomechanical regulation of mesenchymal cell function. Current Opinion in Rheumatology. 2013;25 (1):92-100.","DOI":"10.1097\/BOR.0b013e32835b13cd"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The Journal of Clinical Investigation. 2007;117 (3):524-9.","DOI":"10.1172\/JCI31487"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Saito T, Yokota K, Kobayakawa K, et al. Experimental Mouse Model of Lumbar Ligamentum Flavum Hypertrophy. PloS One. 2017;12 (1):e0169717.","DOI":"10.1371\/journal.pone.0169717"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Salama R, Sadaie M, Hoare M, et al. Cellular senescence and its effector programs. Genes & Development. 2014;28 (2):99-114.","DOI":"10.1101\/gad.235184.113"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Coppe JP, Desprez PY, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annual Review of Pathology. 2010;5:99-118.","DOI":"10.1146\/annurev-pathol-121808-102144"}],"container-title":["Spine Surgery and Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ssrr\/1\/4\/1_1.2017-0023\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T02:00:03Z","timestamp":1719626403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ssrr\/1\/4\/1_1.2017-0023\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.22603\/ssrr.1.2017-0023","relation":{},"ISSN":["2432-261X"],"issn-type":[{"value":"2432-261X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}